Don’t Ever Count Out Microsoft (MSFT) CEO, Says Jim Cramer
Microsoft Corporation (NASDAQ:MSFT)’s shares are up by 7.3% over the past year. Goldman Sachs kept a $655 share price target and a Buy rating on the shares in January.
Insider Monkey Blog
Meta (META) CEO Killed His Stock, Says Jim Cramer
Social media giant Meta Platforms, Inc. (NASDAQ:META)’s shares are flat over the past year, while year-to-date they are down by 4.6%.
People Should Have Listened to NVIDIA (NVDA)’s CEO, Says Jim Cramer
NVIDIA Corporation (NASDAQ:NVDA)’s shares are down by 1.3% year-to-date.
Jim Cramer Recalls Being Bullish on Micron (MU) a Year Ago
Micron Technology, Inc. (NASDAQ:MU) has quietly emerged as one of the top semiconductor stocks in the market. Its shares are up by a whopping 231% over the past year.
10 Buzzing AI Stocks Analysts are Watching
According to Deutsche Bank, 2026 is going to be the hardest year for artificial intelligence.
13 Best Russell 2000 Stocks to Buy Right Now
On January 6, Royce Investment Partners released their outlook for the small-cap stocks in 2026.
What Makes Glaukos (GKOS) a Good Investment?
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Fund” fourth-quarter 2025 investor letter.
Raymond James is Bullish on Electrovaya Inc. (ELVA)
The Fly reported on December 12, 2025, that Raymond James reaffirmed its Strong Buy recommendation and lifted its price objective for Electrovaya Inc.
Macquarie Keeps an Underperform Rating on Li Auto Inc. (LI)
On January 16, 2026, TheFly reported that Macquarie kept its Underperform rating and dropped its price objective for Li Auto Inc. (NASDAQ:LI) from $17 to $15.
SES AI Corporation (SES) & Top Material to Expand Cell Manufacturing Capacity in Korea
SES AI Corporation (NYSE:SES) and Top Material announced plans to work together to increase battery cell manufacturing capacity in Korea for drones and urban air transportation...
Northland Retains an Outperform Rating on Amprius Technologies, Inc. (AMPX)
On January 8, 2026, TheFly reported that Northland selected Amprius Technologies, Inc. (NYSE:AMPX) as a 2026 Top Pick.
HSBC Maintains a Hold Rating on Stellantis N.V. (STLA)
TheFly reported on January 13, 2026, that HSBC increased its price target on Stellantis N.V. (NYSE:STLA) from EUR 8.50 to EUR 10.
Macquarie Keeps an Outperform Rating on NIO Inc. (NIO)
TheFly on January 16, 2026, reported that Macquarie kept its Outperform rating on NIO Inc. (NYSE:NIO). It boosted its price objective from $5.30 to $6.10.
Goldman Sachs is Bullish on General Motors Company (GM)
Goldman Sachs boosted its price objective for General Motors Company (NYSE:GM) to $98 from $93 on January 15, 2026.
Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating
TheFly reported on January 5 that Guggenheim analyst Subbu Nambi raised the price target for VCYT to $50 from $45, maintaining a Buy rating on the stock.
Kinsale Capital Group, Inc. (KNSL) Draws Mixed Analyst Views After New Coverage and Target Revision
TheFly reported on January 15 that Wells Fargo initiated coverage of KNSL with an Overweight rating and a $490 price target.
Palomar Holdings, Inc. (PLMR) Gains Analyst Support as JPMorgan and KBW Raise Targets
The Fly reported on January 7 that JPMorgan raised the PLMR price target to $155 from $145 while maintaining an Overweight rating.
Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves
TheFly reported on January 8 that Truist upgraded PGNY to Buy from Hold and raised its price target to $34 from $28.
Analysts Expect Matador Resources Company (MTDR) to Navigate Lower Oil Prices Effectively
TheFly reported on January 16 that Bank of America raised its price target on MTDR to $52 from $50 and reiterated a Buy rating.
Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves
TheFly reported on January 8 that Morgan Stanley raised its price target on PTCT to $90 from $78 and reiterated an Overweight rating.
Wells Fargo See Upside for Genius Sports Limited (GENI) on Expanding Media and Advertising Opportunity
TheFly reported on January 9, after Wells Fargo upgraded GENI to Overweight from Equal Weight and raised its price target to $16 from $13, the firm conducted a deeper review of...
TD Cowen is Bullish on Alignment Healthcare, Inc. (ALHC) After Medicare Advantage Update
TheFly reported on January 16 that TD Cowen raised its price target on ALHC to $25 from $18.50 and maintained a Buy rating.
Piper Sandler Highlights Arrowhead Pharmaceuticals, Inc. (ARWR) Pipeline With Upcoming Phase III Hypertriglyceridemia Data
TheFly reported on January 13 that Piper Sandler lifted its price target on ARWR to $110 from $100, and reiterated an Overweight rating.
e.l.f Beauty, Inc. (ELF) Maintains Analyst Attention With 2026 Growth Potential
TheFly reported on January 14 that UBS lowered its price target on ELF to $98 from $105 and maintained a Neutral rating on the stock.
Analysts See Mixed Outlook for Shift4 Payments, Inc. (FOUR) Amid Fintech Sector Risks
TheFly reported on January 15 that Deutsche Bank downgraded FOUR to Hold from Buy with a $65 price target.
Barclays Is Bullish on UiPath, Inc. (PATH) Amid Stable IT Spending Outlook
TheFly reported on January 12 that Barclays raised its price target on PATH to $18 from $16 and maintained an Equal Weight rating.
Analysts Highlight Chord Energy Corporation (CHRD)’s Disciplined Approach to Capital and Shareholder Returns
TheFly reported on January 17 that Jefferies lowered its price target on CHRD to $99 from $104 and maintained a Hold rating on the shares as part of a Q4 earnings preview.
Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns
TheFly reported on January 14 that Wells Fargo lowered its price target on INSP to $145 from $160 and maintained an Overweight rating on the shares.
Raymond James Echoes Wix.com Ltd.’s (WIX) Improved Web Development Platform for Complex Projects
Wix.com Ltd (NASDAQ:WIX) is one of the best cheap stocks that will skyrocket.
Jim Cramer Explains Why He Thinks NVIDIA’s Jensen Huang Is the “Greatest Technologist of Our Era”
… NVIDIA… had much more foresight than Micron or anybody else in the industry, so its products are more plentiful… Again, only NVIDIA really saw it coming.
Jim Cramer on Micron CEO: “Sanjay’s Always Preferred Building in America, and That’s One of the Reasons Why I Salute Him”
It’s almost like nobody saw it coming. I’m talking about the severe shortages of all sorts of lower-end semiconductors that go into a data center, especially memory chips.
Jim Cramer on Constellation Energy: “The Fact Is That When the President Gets Involved, It’s Too Uncertain”
Constellation Energy Corporation (NASDAQ:CEG) is one of the stocks Jim Cramer recently looked at.
Jim Cramer Says He “Would Be a Buyer of STMicro”
It’s cheap. It’s good. Now, people say it’s cheap. What do you mean?… like 40 times earnings versus the others with growth? It’s actually okay.
Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It
Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer recently looked at. Asking about the stock, a caller mentioned that they started their position when it was at $39.
Jim Cramer on Smith & Nephew: “This Group, I Do Not Like”
They have to, they have to be sold, okay? I just, this group, I do not like.
Jim Cramer on UiPath: “You Might Have to Wait a Little Bit Longer, But I Think the Upside Is What Beckons There”
UiPath Inc. (NYSE:PATH) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Huntington Bancshares: “They’re Terrific”
Huntington Bancshares (NASDAQ:HBAN) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Alkermes: “I Think It’s a Hold, Maybe a Weak One”
Alkermes plc (NASDAQ:ALKS) is a biopharmaceutical company that develops and sells medicines to treat schizophrenia, bipolar I disorder, and addiction to alcohol or opioids.
Jim Cramer on Super Micro: “Sell, I Don’t Need That”
Super Micro Computer, Inc. (NASDAQ:SMCI) designs and sells modular server and storage systems, including AI, cloud, and edge computing solutions.
Jim Cramer Shows Bullish Sentiment Toward Oscar Health Because of CEO Mark Bertolini
Oscar Health, Inc. (NYSE:OSCR) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Ares Capital: “I Want to Be Very Careful There”
Ares Capital Corporation (NASDAQ:ARCC) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Honeywell: “It’s Finally Getting Credit for All the Things It’s Doing”
Honeywell International Inc. (NASDAQ:HON) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on American Electric Power: “One of My Favorite Utilities for Multiple Years”
American Electric Power Company, Inc. (NASDAQ:AEP) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Agnico Eagle: “This Is My Favorite Gold Company”
Agnico Eagle Mines Limited (NYSE:AEM) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Simon Property’s CEO: “We Think David Simon’s the Best Mall Operator There Is”
Simon Property Group, Inc. (NYSE:SPG) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Crinetics: “That’s a Better Spec Than Aquestive”
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the stocks Jim Cramer recently looked at.
Jim Cramer Says “Let’s Buy CVS, Not UnitedHealth”
UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on Aquestive Therapeutics: “I’m Not Sure If They Deserve the Benefit of the Doubt”
Aquestive Therapeutics, Inc. (NASDAQ:AQST) is one of the stocks Jim Cramer recently looked at.
Jim Cramer on FedEx Freight Spin-Off Plans: “This Deserves a Lot of Attention”
… Just this morning, FedEx filed its Form-10 registration statement for its previously announced freight spinoff.
Hedge Fund Resource Center
